Cardiometabolic
As GLP-1 use scales, dermatology is becoming part of obesity care
A multinational survey presented at EADV 2026 found more self-reported hair, scalp and nail problems among people using GLP-1 receptor agonists than among metabolically similar non-users.
Gestational diabetes is not over at delivery. Postpartum care may be missing the real cardiometabolic warning
Beyond GLP-1s: Lilly is spending billions on a more targeted future in neuroscience
AstraZeneca’s Wainua lowered a disease-causing protein but did not reduce heart complications in a major trial
The same weight loss produced different metabolic benefits. Diet quality may matter as much as kilograms lost
Do patients need maximum-dose tirzepatide forever? New data suggest a middle ground
Sprint interval training triggered a bigger molecular response than 90 minutes of cycling. Bigger is not yet better
One in four Korean adults met MASLD criteria. Four everyday habits were linked to 29% lower odds
More spice did not improve post-meal metabolism. A four-week trial complicates the heart-health story
Gut bacteria could help explain how vegetable-rich diets protect cardiometabolic health
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
Diseases in Cardiometabolic
Explore disease data and country profiles on the IPM Alliance platform.
Explore diseases